Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diabetes
MedTech
Medtronic to spin out diabetes division as $2.8B company
The medtech giant said it aims to complete the spinoff within the next 18 months, with the goal of taking the new company public through an IPO.
Conor Hale
May 21, 2025 10:40am
Roche to spend $550M building Indianapolis HQ into CGM hub
May 13, 2025 12:00pm
Biomea cuts staff, drops leukemia asset in metabolic shift
May 5, 2025 6:59pm
Insulet taps former J&J medtech head Ashley McEvoy to be CEO
Apr 28, 2025 11:00am
Ypsomed sells diabetes business to focus on GLP-1 self-injectors
Apr 23, 2025 6:20am
Medtronic nets FDA approval for Simplera Sync glucose tracker
Apr 21, 2025 11:00am
